Wall Street brokerages forecast that Colgate-Palmolive Company (NYSE:CL) will report earnings of $0.72 per share for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for Colgate-Palmolive Company’s earnings, with the lowest EPS estimate coming in at $0.70 and the highest estimate coming in at $0.72. Colgate-Palmolive Company reported earnings per share of $0.70 during the same quarter last year, which would suggest a positive year-over-year growth rate of 2.9%. The company is expected to issue its next quarterly earnings report before the market opens on Friday, July 21st.

On average, analysts expect that Colgate-Palmolive Company will report full-year earnings of $2.92 per share for the current fiscal year, with EPS estimates ranging from $2.87 to $2.95. For the next year, analysts anticipate that the firm will report earnings of $3.15 per share, with EPS estimates ranging from $3.05 to $3.23. Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Colgate-Palmolive Company.

Colgate-Palmolive Company (NYSE:CL) last issued its quarterly earnings results on Friday, April 28th. The company reported $0.67 EPS for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.01. Colgate-Palmolive Company had a return on equity of 3,725.55% and a net margin of 16.31%. The company had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.80 billion. During the same quarter last year, the business earned $0.63 earnings per share. Colgate-Palmolive Company’s revenue was up .0% on a year-over-year basis.

A number of equities analysts have weighed in on the company. Royal Bank Of Canada restated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive Company in a research note on Monday, April 24th. Jefferies Group LLC assumed coverage on Colgate-Palmolive Company in a research note on Tuesday, April 18th. They issued a “hold” rating and a $78.00 target price on the stock. Citigroup Inc. upped their target price on Colgate-Palmolive Company from $70.00 to $75.00 and gave the stock a “neutral” rating in a research note on Tuesday, March 21st. Zacks Investment Research upgraded Colgate-Palmolive Company from a “sell” rating to a “hold” rating in a research note on Thursday, March 30th. Finally, Vetr lowered Colgate-Palmolive Company from a “buy” rating to a “hold” rating and set a $76.67 target price on the stock. in a research note on Wednesday, May 17th. Fourteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Colgate-Palmolive Company currently has an average rating of “Hold” and a consensus price target of $75.41.

Colgate-Palmolive Company (CL) traded up 1.03% during mid-day trading on Friday, reaching $76.31. The company had a trading volume of 772,703 shares. The stock has a 50 day moving average price of $74.49 and a 200-day moving average price of $71.10. The stock has a market capitalization of $67.40 billion, a P/E ratio of 27.54 and a beta of 0.82. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.12%. The ex-dividend date of this dividend is Friday, July 14th. Colgate-Palmolive Company’s dividend payout ratio (DPR) is currently 57.76%.

ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Anticipate Colgate-Palmolive Company (CL) Will Announce Earnings of $0.72 Per Share” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.americanbankingnews.com/2017/06/23/zacks-brokerages-anticipate-colgate-palmolive-company-cl-will-announce-earnings-of-0-72-per-share.html.

In other news, VP Daniel B. Marsili sold 14,000 shares of the stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $73.97, for a total value of $1,035,580.00. Following the completion of the transaction, the vice president now owns 73,904 shares of the company’s stock, valued at approximately $5,466,678.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard J. Kogan sold 8,000 shares of the stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $71.92, for a total value of $575,360.00. Following the completion of the transaction, the director now directly owns 73,065 shares of the company’s stock, valued at approximately $5,254,834.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,666 shares of company stock valued at $3,184,972. Company insiders own 1.02% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Quest Investment Management Inc. OR raised its position in shares of Colgate-Palmolive Company by 10.5% in the fourth quarter. Quest Investment Management Inc. OR now owns 76,609 shares of the company’s stock valued at $5,013,000 after buying an additional 7,292 shares in the last quarter. Chickasaw Capital Management LLC raised its position in shares of Colgate-Palmolive Company by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock valued at $1,238,000 after buying an additional 11,605 shares in the last quarter. Meritage Portfolio Management raised its position in shares of Colgate-Palmolive Company by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock valued at $7,017,000 after buying an additional 255 shares in the last quarter. Eastern Bank raised its position in shares of Colgate-Palmolive Company by 0.8% in the first quarter. Eastern Bank now owns 10,939 shares of the company’s stock valued at $801,000 after buying an additional 89 shares in the last quarter. Finally, Comerica Bank raised its position in shares of Colgate-Palmolive Company by 3.9% in the fourth quarter. Comerica Bank now owns 566,367 shares of the company’s stock valued at $37,312,000 after buying an additional 21,184 shares in the last quarter. 74.12% of the stock is owned by hedge funds and other institutional investors.

About Colgate-Palmolive Company

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive Company (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.